SCHEMBL126287

SCHEMBL126287

CCOc1cccc(CO)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.55
CYP3A4 P08684 2/20 0.55
SMN1; SMN2 Q16637 4/20 0.53
TSHR P16473 2/20 0.53
CHRM2 P08172 1/20 0.50
CHRM1 P11229 1/20 0.50
CHRM3 P20309 1/20 0.50
GPBAR1 Q8TDU6 1/20 0.49
CYSLTR1 Q9Y271 1/20 0.49
NOTUM Q6P988 1/20 0.49
DHFR P00374 1/20 0.48
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46
KDR P35968 1/20 0.46
MAPK1 P28482 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13777298 0.86 SMN1; SMN2 (0.52) TP53CYP3A4SMN1; SMN2TSHRCHRM2
SCHEMBL2933175 0.85 KMT2A (0.56) CYP3A4SMN1; SMN2TSHRGPBAR1CYSLTR1
SCHEMBL8045887 0.85 CYP4F2 (0.67) TP53CYP3A4SMN1; SMN2CHRM2CHRM1
SCHEMBL14724421 0.84 TSHR (0.48) SMN1; SMN2TSHRGPBAR1CYSLTR1KDM4E
SCHEMBL131598 0.83 TP53 (0.59) TP53CYP3A4SMN1; SMN2TSHRCHRM2
SCHEMBL5247746 0.83 TP53 (0.59) TP53CYP3A4SMN1; SMN2TSHRCHRM2
SCHEMBL31061915 0.83 TP53 (0.59) TP53CYP3A4SMN1; SMN2TSHRCHRM2
SCHEMBL16902891 0.83 TSHR (0.56) SMN1; SMN2TSHRGPBAR1CYSLTR1CYP4F2
SCHEMBL31474675 0.83 TP53 (0.50) TP53CYP3A4SMN1; SMN2TSHRCHRM2
SCHEMBL8036345 0.83 GGPS1 (0.54) SMN1; SMN2TSHRDHFRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9616459-B1 Polymeric coatings for fortification of visible, infrared, and laser optical devices LOCKHEED MARTIN CORPORATION (US) 2017-04-11 US claimed
EP-0539515-B1 NON-CORROSIVE COMPOSITION AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS MICROPROBE CORP (US) 1998-10-21 EP claimed
EP-0539515-A4 1995-04-26 EP claimed
US-5393672-A Using benzyl alcohol and derivatives MICROPROBE CORPORATION (US) 1995-02-28 US claimed
EP-0539515-A1 NON-CORROSIVE COMPOSITION AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS MICROPROBE CORPORATION (US) 1993-05-05 EP claimed
US-5130423-A Benzyl alcohol or derivatives for extraction MICROPROBE CORPORATION (US) 1992-07-14 US claimed
WO-1992000983-A1 NON-CORROSIVE COMPOSITION AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS MICROPROBE CORPORATION (US) 1992-01-23 WO claimed
US-20230232827-A1 METHOD FOR CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QoI FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-27 US disclosed
US-11289238-B2 Compositions for the filling of high aspect ratio vertical interconnect access (VIA) holes HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC (US) 2022-03-29 US disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
WO-2021112933-A1 COMPOSITIONS FOR THE FILLING OF HIGH ASPECT RATIO VERTICAL INTERCONNECT ACCESS (VIA) HOLES HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC (US) 2021-06-10 WO disclosed
US-20210174983-A1 COMPOSITIONS FOR THE FILLING OF HIGH ASPECT RATIO VERTICAL INTERCONNECT ACCESS (VIA) HOLES HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC 2021-06-10 US disclosed
CN-107074721-B Method for preparing terephthalic acid diester by refluxing alcohol enrichment 巴斯夫欧洲公司 2021-01-08 CN disclosed
EP-0244632-B1 TUBE BUNDLE REACTOR, ITS USE IN EXOTHERMAL ORGANIC REACTIONS AND PROCESS FOR THE PREPARATION OF KETONES AND ALDEHYDES BASF Aktiengesellschaft (DE) 1991-02-20 EP disclosed
EP-0093010-B1 ALPHA-HYDROXYETHYLPHOSPHINATES, AND THEIR PRODUCTION AND USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-06-11 EP disclosed
US-4554111-A α-Hydroxyethylphosphinates, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-11-19 US disclosed
US-4544652-A α-Hydroxyethylphosphinates, and their use as fungicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-10-01 US disclosed
EP-0093010-A2 Alpha-hydroxyethylphosphinates, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-11-02 EP disclosed
US-4224254-A OXIDATION OF AROMATIC ALCOHOLS, SILVER CATALYST BASF AKTIENGESELLSCHAFT (DE) 1980-09-23 US disclosed
US-4199499-A ANALGESICS ELI LILLY AND COMPANY (US) 1980-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230232827-A1 METHOD FOR CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QoI FUNGICIDES CYC1, SQOR, MT-CO3 TP53 2943/4885CYP3A4 350/4885SMN1; SMN2 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.